OIG, CMS or DOJ? Look at options before making self-disclosure

Why This Topic Matters

Providers, compliance officers, billing staff, and health care counsel need a clear way to evaluate disclosure options before regulators discover a problem. Choosing the right disclosure pathway can affect exposure, settlement handling, and how a compliance issue is framed.

Article Sections

1. Self-disclosure options and agency pathways

   Introduces the federal and state disclosure channels that may be available when a provider identifies a potential compliance problem. Describes the general types of matters each pathway may address and the organizations involved.

2. How to choose a disclosure route

   Discusses the practical factors that influence whether a matter is directed to one agency or another. Addresses how the presence or absence of suspected fraud can affect the choice of forum.

3. How much to disclose?

   Explains the general question of when an identified issue may warrant a broader disclosure response. Covers the role of overpayment review, sampling, and issue scope at a high level.

4. Penalties appertaining to health care

   Provides a broad summary of penalty categories tied to major health care fraud and abuse frameworks. The section is presented as background for understanding why self-disclosure decisions matter.